{"url_path":"/sec/pmi/8-k/2026-05-21/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-005568-index.html","accession_number":"0001829126-26-005568","cik":"0002030617","ticker":"PMI","issuer_name":"Picard Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-005568-index.html","primary_entity_key":"0002030617","primary_entity_name":"Picard Medical, Inc."},"word_count":144,"has_tables":true,"body_markdown":"**Item 7.01.**\n**Regulation FD Disclosure.**\n\n \n\nOn May 21, 2026, the Company issued a press release disclosing receipt of the Notices and the specific continued listing standards that the Company has fallen\nbelow. A copy of the press release is furnished as Exhibit 99.1 and incorporated herein by reference.\n\n \n\nThe information included in Item 7.01,\nincluding the exhibit hereto, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the\nExchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any\nfiling of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date\nhereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific\nreference in such filing\n\n \n\n1"}